The potential role for probiotic yogurt for people living with HIV/AIDS

Gut Microbes

Volumn 1, Issue 6, 2010, Pages 411-414

  Reid, Gregor ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Africa; Community kitchen; Diarrhea; Hiv aids; Probiotics; Yogurt

Indexed keywords

PROBIOTIC AGENT; YOGHURT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; DEVELOPING COUNTRY; FOOD AND AGRICULTURE ORGANIZATION; FOOD INTAKE; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; LACTOBACILLUS RHAMNOSUS; NONHUMAN; NUTRITIONAL SUPPORT; WORLD HEALTH ORGANIZATION; DIET; IMMUNOLOGY; METHODOLOGY; MICROBIOLOGY; REVIEW; UNITED NATIONS;

DEVELOPING COUNTRIES; DIET; HIV INFECTIONS; HUMANS; PROBIOTICS; UNITED NATIONS; YOGURT;

EID: 79251503914     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.4161/gmic.1.6.14079     Document Type: Article

References (17)

1. FAO/WHO. Evaluation of health and nutritional properties of powder milk and live lactic acid bacteria. Food and Agriculture Organization of the United Nations and World Health Organization Expert Consultation Report 2001; http://www.fao.org/ag/agn/Probio/probio.htm.
2. Hekmat S, Reid G. Survival of Lactobacillus reuteri RC-14 and Lactobacillus rhamnosus GR-1 in milk. Int J Food Sci and Technol 2007; 42:615-9.
3. Hekmat S, Soltani H, Reid G. Growth and survival of Lactobacillus reuteri RC-14 and Lactobacillus rhamnosus GR-1 in yogurt for use as a functional food. Innovative Food Science and Emerging Technologies 2008; 10:293-6.
4. Hekmat S, Reid G. Sensory properties of probiotic yogurt is comparable to standard yogurt. Nutr Res 2006; 26:163-6.
5. Baroja ML, Kirjavainen PV, Hekmat S, Reid G. Antiinflammatory effects of probiotic-yogurt in inflammatory bowel disease patients. Clin Experimental Immunol 2007; 149:470-9.
6. Anukam KC, Osazuwa EO, Osadolor HB, Bruce AW, Reid G. Yogurt containing probiotic Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 helps resolve moderate diarrhea and increases CD4 count in HIV/ AIDS patients. J Clin Gastroenterol 2008; 42:239-43.
7. UNAIDS. Sub-Saharan Africa: AIDS epidemic update (Regional Summary) UNAIDS & WHO. 2008; http://data.unaids.org/pub/Report/2008/jc1526_epibriefs_ssafrica_en.pdf.
8. UNAIDS. Report on the global AIDS epidemic, Joint United Nations Programme on HIV/AIDS. 2004; http://www.unaids.org/bangkok2004/report.html.
9. TACAIDS (Tanzania Commission for HIV/AIDS). National Multi-Sectoral Strategic Framework on HIV/AIDS 2003-2007, Dar Es Salaam, Tanzania. 2003. http://www.moh.go.tz/documents/aids_nmsf2003.pdf.
10. DHAPP (Department of Defense HIV/AIDS Prevention Program). Winning battles in the war against HIV/AIDS. 2005; http://www.nhrc.navy.mil/programs/dhapp/countryreports/yearly05/tanzania05.pdf.
11. Irvine SL, Hummelen R, Hekmat S, Looman CW, Habbema JD, Reid G. Probiotic yogurt consumption is associated with an increase of CD4 count among people living with HIV/AIDS. J Clin Gastroenterol 2010; 44:e201-5.
12. Lawn SD, Myer L, Bekker LG, Wood R. CD4 cell count recovery among HIV infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa. BMC Infect Dis 2006; 6:59.
13. Holmes CB, Wood R, Badri M, Zilber S, Wang B, Maartens G, et al. CD4 decline and incidence of opportunistic infections in Cape Town, South Africa: Implications for prophylaxis and treatment. J AIDS 2006; 42:464-9.
14. Urassa W, Bakari M, Sandström E, Swai A, Pallangyo K, Mbena E, et al. Rate of decline of absolute number and percentage of CD4 T lymphocytes among HIV-1-infected adults in Dar es Salaam, Tanzania. AIDS 2004; 18:433-8.
15. Hummelen R, Fernandes AD, Macklaim JM, Dickson RJ, Changalucha J, Gloor GB, et al. Deep sequencing of the vaginal microbiome in HIV patients. PLoS ONE 2010; 5:12078.
16. Moreno S, López Aldeguer J, Arribas JR, Domingo P, Iribarren JA, Ribera E, et al. HIV 2020 Project. The future of antiretroviral therapy: Challenges and needs. J Antimicrob Chemother 2010; 65:827-35.
17. Vidal F, Gutiérrez F, Gutiérrez M, Olona M, Sánchez V, Mateo G, et al. Pharmacogenetics of adverse effects due to antiretroviral drugs. AIDS Rev 2010; 2:15-30.